Millennium Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Millennium Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.61M	Buy	+250,000	New	+$7.32M	﹤0.01%	2622
2025 Q3	–	Sell	-152,500	Closed	-$3.71M	–	6004
2025 Q2	$3.71M	Buy	+152,500	New	+$3.34M	﹤0.01%	3288
2025 Q1	–	Sell	-660,000	Closed	-$15.5M	–	5825
2024 Q4	$15.5M	Buy	660,000 +500,000	+313%	+$12.3M	0.01%	1736
2024 Q3	$4.1M	Sell	160,000 -7,600	-5%	-$194K	﹤0.01%	3022
2024 Q2	$3.94M	Hold	167,600	–	–	﹤0.01%	2940
2024 Q1	$4.82M	Buy	167,600 +7,600	+5%	+$229K	﹤0.01%	2900
2023 Q4	$5.25M	Buy	160,000 +60,000	+60%	+$1.63M	﹤0.01%	2748
2023 Q3	$2.79M	Hold	100,000	–	–	﹤0.01%	3243
2023 Q2	$3.41M	Hold	100,000	–	–	﹤0.01%	3017
2023 Q1	$3.01M	Hold	100,000	–	–	﹤0.01%	3047
2022 Q4	$2.82M	Buy	+100,000	New	+$3.17M	﹤0.01%	3267
2022 Q2	–	Sell	-50,000	Closed	-$2.3M	–	6941
2022 Q1	$2.3M	Buy	50,000 +30,000	+150%	+$1.43M	﹤0.01%	3748
2021 Q4	$1.23M	Buy	20,000 +10,000	+100%	+$691K	﹤0.01%	4220
2021 Q3	$747K	Sell	10,000 -10,000	-50%	-$839K	﹤0.01%	4961
2021 Q2	$1.85M	Buy	+20,000	New	+$1.7M	﹤0.01%	4061
2021 Q1	–	Sell	-75,000	Closed	-$7M	–	5885
2020 Q4	$7M	Buy	+75,000	New	+$5.98M	0.01%	2123

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Millennium Management's ARKG Position: Q1 2025 in Review

Millennium Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 22,039 shares — an estimated $519K sold.

Millennium Management first reported a position in ARKG in Q2 2020 and held it in 15 quarters. The position peaked at $9.38M in Q1 2021. 215 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

Millennium Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
Millennium Management sold 22,039 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $519K.
Millennium Management first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 15 quarters.
Millennium Management's ARK Genomic Revolution ETF position peaked at $9.38M in Q1 2021.
215 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.